Recent Press Releases

PPD® Laboratories Opens Central Lab in Shanghai, China

WILMINGTON, N.C.--Pharmaceutical Product Development, LLC (PPD) has opened a central laboratory in Shanghai, China, to deliver global scientific and technical laboratory expertise to meet growing...

Full-Service CRO CTI Broadens Use of Medidata Technology Platform for More Efficient, Higher Quality Clinical Trials

NEW YORK--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that CTI Clinical Trial and Consulting Services (CTI), a...

Catalent Completes $52 Million Expansion Program For Advanced Oral Solid Manufacturing Solutions At Winchester, KY, Facility

Somerset, N.J. – Catalent Pharma Solutions, a unit of Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics...

Quintiles and Hospital Italiano of Buenos Aires announce agreement to accelerate clinical development

RESEARCH TRIANGLE PARK, N.C.--Quintiles today announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company's Prime Site program. Hospital Italiano is...

Ophthalmology-focused CROs, Iris Pharma and Oculos Clinical Research Announce Strategic Alliance to Offer International Specialized Services to the Ophthalmic Market

LA GAUDE, France & TAMPA, Fla.--Iris Pharma, a European ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug/device development services, and...

Aptuit LLC and Axxam SpA announce Strategic Alliance for Integrated Drug Discovery Services

GREENWICH, Conn. and MILAN -- Aptuit LLC, a premier global drug discovery and development CRO and Axxam SpA, a leading discovery company with expertise in target biology and a broad range of early...

Clinipace Worldwide Expands European Operations with Acquisition of Accovion

Accovion Strengthens Clinipace's Operational and Therapeutic Expertise Within Europe MORRISVILLE, N.C. April 13, 2015 – Clinipace Worldwide, a global digital contract research organization...

Protea Announces Agreement to Acquire vivoPharm

Combined Company to Develop and Market New Services for Pharmaceutical R&D MORGANTOWN, W.Va. -- Protea Biosciences Group, Inc. (OTCQB:PRGB) ("Protea") announced today that it has...

WuXi PharmaTech Lists Shares of Small-Molecule Manufacturing Subsidiary STA on New Third Board in China

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries,...

PAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy Programs

BOSTON -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced three new academic programs at the PAREXEL Academy. The offerings...

Catalent Acquires Pharmapak, Australia

Somerset, N.J. – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today...

PPD and SNBL Complete Joint Venture to Provide Japanese Clinical Development Services and Additional Collaborations

WILMINGTON, N.C. & TOKYO--Pharmaceutical Product Development, LLC (PPD) and Shin Nippon Biomedical Laboratories Ltd. (SNBL) (TSE:2395) today announced the closing of an agreement to form a joint...

AMRI to Close Holywell, U.K. API Manufacturing Facility

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that it has decided to close its Holywell, U.K. facility following a consultation process with employee representatives. The Holywell site provides...

TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals

BRIDGEWATER, N.J. & FORT WORTH, Texas--Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. The...

PRA Health Sciences Expands Global Phase I Patient Strategy

RALEIGH, N.C. -- PRA Health Sciences (PRA) is enhancing its global Phase I patient strategy and increasing its clinical footprint with the expansion of its Early Development Services (EDS). These...

Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device...

X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation

WALTHAM & CAMBRIDGE, Mass.--X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics,...

Quintiles and Quest Diagnostics to Form Joint Venture to Provide Global Clinical Trials Laboratory Services

Combines the complementary strengths and scale of leading biopharmaceutical services and diagnostic information services providers New entity creates superior value proposition through the depth...

Recipharm and Adroit Science form collaboration to expand service offering

Recipharm AB and Adroit Science AB today announce the formation of a new strategic collaboration. Adroit Science AB will supportRecipharm's pharmaceutical development with high quality solid...